The primary purpose of this study is to compare the time, risk and cost savings of 2 patient groups who receive FDA approved left ventricular pacing leads.
The purpose of this study is to: a) examine the usefulness of placing an epicardial LV lead at the time of open chest surgery in patients who are likely to benefit from a CRT system following their surgery; b) compare differences between patients who receive LV leads using the transvenous approach and those patients who receive LV leads using the epicardial approach; and c) assess the cost effectiveness of placing the LV lead via the transvenous versus the epicardial approaches.
Study Type
OBSERVATIONAL
Enrollment
40
Epicardial left ventricular lead placement
Transvenous left ventricular lead implant
University of Kansas Medical Center
Kansas City, Kansas, United States
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.